Neurocysticercosis: Management issues

Indian Pediatrics

Volumn 43, Issue 3, 2006, Pages 227-235

  Dua, Tarun ^a   Aneja, S ^b,c  

^a UNIVERSITY COLLEGE OF MEDICAL SCIENCES   (India)

^b KALAWATI SARAN CHILDREN'S HOSPITAL   (India)

^c LHMC Campus ^*  (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; ANTICONVULSIVE AGENT; CORTICOSTEROID; LARVICIDAL AGENT; PRAZIQUANTEL;

APHASIA; BRAIN CYST; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTAMINATION; CYSTICERCOSIS; EPILEPSY; FOOD HANDLING; HUMAN; LONG TERM CARE; NEUROCYSTICERCOSIS; NEUROIMAGING; NEUROSURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW; SEIZURE; SEROLOGY; TAENIA SOLIUM; TREATMENT OUTCOME;

ADRENAL CORTEX HORMONES; ANTICONVULSANTS; ANTIPARASITIC AGENTS; DIAGNOSTIC IMAGING; HUMANS; NEUROCYSTICERCOSIS; SEROLOGIC TESTS; TREATMENT OUTCOME;

EID: 33645553517     PISSN: 00196061     EISSN: 00196061     Source Type: Journal    
DOI: None     Document Type: Review

References (41)

1. Del Brutto OH, Santibanez R, Noboa CA, Aguirre R, Diaz E, Alarcon TA. Epilepsy due to neurocysticercosis: analysis of 203 patients. Neurology 1992; 42: 389-392.
2. Commission on Tropical Diseases of the International League Against Epilepsy. Relationship between epilepsy and tropical diseases. Epilepsia 1994; 35: 89-93.
3. Medina MT, Rosas E, Rubio-Donnadieu F, Sotelo J. Neurocysticercosis as the main cause of late-onset epilepsy in Mexico. Arch Intern Med 1990; 150: 325-327.
4. Kalra V, Sethi A. Childhood neurocysticercosis-epidemiology, diagnosis and course. Acta Pediatr Jpn 1992; 34: 365-370.
5. Monteiro L, Nunes B, Mendonca D, Lopes J. Spectrum of epilepsy in neurocysticercosis: A long-term follow-up of 143 patients. Acta Neurol Scand 1995; 92: 33-40.
6. Del Brutto OH, Rajshekhar V, White AC Jr, Tsang VC, Nash TE, Takayanagui OM, et al. Proposed diagnostic criteria for neurocysticercosis. Neurology 2001; 57: 177-183.
7. Garg RK. Proposed diagnostic criteria for neurocysticercosis. Neurology 2002; 58: 1315.
8. Nash TE, Neva FA. Recent advances in the diagnosis and treatment of cerebral cysticercosis. N Engl J Med 1984; 311: 1492-1496.
9. Martinez HR, Rangel-Guerra R, Elizondo G, Gonzalez J, Todd LE, Ancer J, et al. MR imaging in neurocysticercosis: A study of 56 cases. Am J Neuroradiol 1989; 10: 1011-1019.
10. Murthy JM, Yangala R. Etiological spectrum of localization-related epilepsies in childhood and the need for CT scan in children with partial seizures with no obvious causation a study from South India. J Trop Pediatr 2000; 46: 202-206.
11. Aggarwal A, Aneja S, Taluja V, Kumar R, Bhardwaj K. Etiology of partial epilepsy. Indian Pediatr 1998; 35: 49-52.
12. Rajshekhar V, Chandy MJ. Incidence of solitary cysticercus granuloma. In: Rajshekhar V, Chandy MJ, eds. Solitary cysticercus granuloma: the disappearing lesion. Chennai: Orient Longman Ltd; 2000, p 12-28.
13. Rajshekhar V, Haran RP, Prakash GS, Chandy MJ. Differentiating solitary small cysticercus granulomas and tuberculomas in patients with epilepsy. Clinical and computerized tomographic criteria. J Neurosurg 1993; 78: 402-407.
14. Jayasundar R, Singh VP, Raghunathan P, Jain K, Banerji AK. Inflammatory-granulomas: evaluation with proton MRS. NMR Biomed 1999; 12: 139-144.
15. Rosas N, Sotelo J, Nieto D. ELISA in the diagnosis of neurocysticercosis. Arch Neuro1 1986; 43: 353-356.
16. Tsang VC, Brand JA, Boyer AE. An enzyme-linked immunoelectrotransfer blot assay and glycoprotein antigens for diagnosing human cysticercosis (Taenia solium). J Infect Dis 1989; 159: 50-59.
17. Wilson M, Bryan RT, Fried JA, Ware DA, Schantz PM, Pilcher JB, et al. Clinical evaluation of the cysticercosis enzyme-linked immunoelectrotransfer blot in patients with neurocysticercosis. J Infect Dis 1991; 164: 1007-1009.
18. Erhart A, Dorny P, Van De N, Vien HV, Thach DC, Toan ND, et al. Taenia solium cysticercosis in a village in northern Vietnam: seroprevalence study using an ELISA for detecting circulating antigen. Trans R Soc Trop Med Hyg 2002; 96: 270-272.
19. Ohsaki Y, Matsumoto A, Miyamoto K, Kondoh N, Araki K, Ito A, et al. Neurocysticercosis without detectable specific antibody. Intern Med 1999; 38: 67-70.
20. Garcia HH, Parkhouse RM, Gilman RH, Montenegro T, Bernal T, Martinez SM, et al. Cysticercosis Working Group in Peru. Serum antigen detection in the diagnosis, treatment, and follow-up of neurocysticercosis patients. Trans R Soc Trop Med Hyg 2000; 94: 673-676.
21. Garcia HH, Evans CA, Nash TE, Takayanagui OM, White AC Jr, Botero D, et al. Current consensus guidelines for treatment of neurocysticercosis. Clin Microbiol Rev 2002; 15: 747-756.
22. Salinas R. Prasad K. Drugs for treating neurocysticercosis (tapeworm infection of brain) Cochrane Database Syst Rev 2000; (2): CDOO0215.
23. Kramer LD. Medical treatment of cysticercosis-ineffective. Arch Neurol 1995; 52: 101-210.
24. Carpio A, Santillan F, Leon P, Flores C, Hauser WA. Is the course of neurocysticercosis modified by treatment with antihelminthic agents? Arch Intern Med 1995; 155: 1982-1988.
25. Garcia HH, Pretell EJ, Gilman RH, Martinez SM, Moulton LH, Del Brutto OH, et al. Cysticercosis Working Group in Peru. A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis. N Engl J Med 2004; 350: 249-258.
26. Rajshekhar V. Albendazole therapy for persistent, solitary cysticercus granulomas in patients with seizures. Neurology 1993; 43: 1238-1240.
27. Padma MV, Behari M, Misra NK, Ahuja GK. Albendazole in single CT ring lesions in epilepsy. Neurology 1994; 44: 1344-1346.
28. Baranwal AK, Singhi PD, Khandelwal N, Singhi SC. Albendazole therapy in children with focal seizures and single small enhancing computerized tomographic lesions: A randomized, placebo-controlled, double blind trial. Pediatr Infect Dis J 1998; 17: 696-700.
29. Kalra V, Dua T, Kumar V. Efficacy of albendazole and short-course dexamethasone treatment in children with 1 or 2 ring-enhancing lesions of neurocysticercosis: A randomized controlled trial. J Pediatr 2003; 143: 111-114.
30. Gogia S, Talukdar B, Choudhury V, Arora BS. Neurocysticercosis in children: Clinical findings and response to albendazole therapy in a randomized, double-blind, placebo-controlled trial in newly diagnosed cases. Trans R Soc Trop Med Hyg 2003; 97: 416-421.
31. Nash TE. Human case management and treatment of cysticercosis. Acta Trop 2003; 87: 61-69.
32. Garcia HH, Gilman RH, Horton J, Martinez M, Herrera G, Altamirano J, et al. Albendazole therapy for neurocysticercosis: a prospective double-blind trial comparing 7 versus 14 days of treatment. Cysticercosis Working Group in Peru. Neurology 1997; 48: 1421-1427.
33. Sotelo J, Penagos P, Escobedo F, Del Brutto OH. Short course of albendazole therapy for neurocysticercosis. Arch Neuro1 1988; 45: 1130-1133.
34. Bittencourt PR, Gracia CM, Martins R, Fernandes AG, Diekmann HW, Jung W. Phenytoin and carbamazepine decreased oral bioavailability of praziquantel. Neurology 1992; 42: 492-496.
35. Singhi PD, Jain V, Khandelwal N. Corticosteroids versus albendazole for treatment of single small enhancing computed tomographic lesions in children with neurocysticercosis. J Child Neurol 2004; 19: 323-327.
36. Mall RK, Agarwal A, Garg RK, Kar AM, Shukla R. Short course of prednisolone in Indian patients with solitary cysticercus granuloma and new-onset seizures Epilepsia 2003; 44: 1397-1401.
37. Singhi PD, Dinakaran J, Khandelwal N, Singhi SC. One vs. two years of anti-epileptic therapy in children with single small enhancing CT lesions. J Trop Pediatr 2003; 49: 274-278.
38. Rajshekhar V, Jeyaseelan L. Seizure outcome in patients with a solitary cerebral cysticercus granuloma. Neurology 2004; 62: 2236-2240.
39. Del Brutto OH. Prognostic factors for seizure recurrence after withdrawal of anti- epileptic drugs in patients with neurocysticercosis. Neurology 1994; 44: 1706-1709.
40. Garcia HH, Del Brutto OH, Nash TE, White AC Jr, Tsang VC, Gilman RH. New concepts in the diagnosis and management of neurocysticercosis (Taenia solium). Am J Trop Med Hyg 2005; 72: 3-9.
41. Pradhan S, Kathuria MK, Gupta RK. Perilesional gliosis and seizure outcome: a study based on magnetization transfer magnetic resonance imaging in patients with neurocysticercosis. Ann Neurol 2000; 48: 181-187.